Φαρμακευτικός Κόσμος, Συμπληρώματα Διατροφής

42 35. Cho E, Hunter DJ, Spiegelman D, Albanes D, Beeson WL, van den Brandt PA et al. (2006) Intakes of vitamins A, C and E and folate and multivitamins and lung cancer: a pooled analysis of 8 prospective studies. Int J Cancer 118, 970–978. 36. Christina E Carvey, Emily K Farina and Harris R Lieberman: Confidence in the efficacy and safety of dietary supplements among United States active duty army personnel. BMC Complementary and Alternative Medicine 2012, 12:182 37. Clayman, C.B. (ed.). 1994. The American Medical Association Family Medical Guide. New York, NY: Random House. 38. Conklin KA. Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer. 2000;37(1):1-18. 39. Cook, J. D. & Monsen, E. R. (1977) Vitamin C, the common cold, and iron absorption. American Journal of Clinical Nutrition, 30, 235–41. 40. Cooke HM. Lovastatin- and niacin-induced rhabdomyolysis. Hosp Pharm. 1994;29:33-34. 41. Corrigan JJ Jr, Marcus FI. Coagulopathy associated with vitamin E ingestion. JAMA. 1974;230:1300-1301. 42. Cosmetic Ingredient Review Expert Panel, “Final report on the safety assessment of Aloe andongensis extract, Aloe andongensis leaf juice, Aloe arborescens leaf extract, Aloe arborescens leaf juice, Aloe arborescens leaf protoplasts, Aloe barbadensis flower extract, Aloe barbadensis leaf, Aloe barbadensis leaf extract, Aloe barbadensis leaf juice, Aloe barbadensis leaf polysaccharides, Aloe barbadensis leaf water, ferox leaf extract,,” International Journal of Toxicology, vol. 26, Supplement 2, pp. 1–50, 2007. 43. Cosyns, J. P., Jadoul, M., Squifflet, J. P., Wese, F. X., and van Ypersele de Strihou, C. (1999). Urothelial lesions in Chinese herb nephropathy. Am. J. Kidney Dis. 33,1011–1017. 44. Council For Responsible Nutrition (CRN): Americans confident in dietary supplements, says new ipsos-public affairs survey. Washington, D.C: Council for Responsible Nutrition (CRN); 2004. http://www.crnusa.org/ PR04_1025ConsumerConf.html. 45. Council For Responsible Nutrition (CRN): Supplement usage, consumer confidence remains steady. Washington, D.C: Council for Responsible Nutrition (CRN); 2010. http:// www.crnusa.org/prpdfs/ CRNPR10ConsumerSurvey_Usage+Confidence.pdf. 46. Cumming, F., Briggs, M. & Briggs, M. (1981) Clinical toxicology of vitamin supplements. In Vitamins in Human Biology and Medicine. (Ed. M. H. Briggs), pp. 187–243. CRC Press, Inc., Boca Raton, Florida. 47. Czeizel, A. E. & Dudás, I. (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplemen- tation. New England Journal of Medicine, 327, 1832–5. 48. Dalton, K. & Dalton, M. J. T. (1987) Characteristics of pyridoxine overdose neuropathy syndrome. Acta Neurologica Scandinavica, 76, 8–11. 49. Dat A. D., Poon F., Pham K. B., “Aloe vera for treating acute and chronic wounds,” Cochrane Database Systematic Reviews, vol. 2. Article ID CD008762, 2012. 50. De Lima Toccafondo Vieira M, Huang SM. Botanical-drug interactions: A scientific perspective. Planta Med. 2012 Sep;78(13):1400-15. 51. DeFeudis FV, Drieu K. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets. 2000;1(1):25–58. 52. DeKosky ST, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for prevention of dementia. JAMA. 2008;300(19):2253–2262. 53. Desrumaux, C., Deckert, V., Athias, A., Masson, D., Lizard, G., Palleau, V., Gambert, P. & Lagrost, L. (1999) Plasma phospholipid transfer protein prevents vascular endothe- lium dysfunction by delivering α-tocopherol to endothelial cells. FASEB Journal, 13, 883–92. 54. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code Relating to Medicinal Products for Human Use, http:// ec.europa.eu /health/files/eudralex/vol-1/dir 2001 83/2001 83 ec en.pdf. 55. Directive 2004/24/EEC of the European parliament and of the council of 31 March 2004 amending, as regards traditional herbal medicinal products, directive 2001/83/EC on community code relating to medicinal products for human use,” Official Journal of the European Communities, vol. L136, pp. 85–90, 2004. 56. Domke A, Großklaus R, Niemann B, et al. (2005) Use of Vitamins in Foods. Toxicological and Nutritional Aspects. Part I, Part II. Berlin: German Institute of Risk Assessment. 57. Donovan JL, DeVane CL, Chavin KD. Multiple night time doses of valerian had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers. Drug Metabol Dispos. 2004; 32(12):1333–1336. 58. Dunnick, J. K., and Nyska, A. (2013). The toxicity and pathology of selected dietary herbal medicines. Toxicol. Pathol. 41, 374–386. 59. Dwyer JT, Garceau AO, Evans M. Do adolescent vitamin-mineral supplement users have better nutrient intakes than nonusers? Observations from the CATCH tracking study. J Am Diet Assoc 2001;101: 1340 – 6. 60. Dwyer JT, Picciano MF, Raiten DJ. Food and dietary supplement databases for What We Eat in America-NHANES. J Nutr. 2003;133(suppl):624S–634S 61. EFS A-efsa.europa.eu/en/topics/topic/supplements.htm 62. Eikelboom JW, Lonn E, Genest Jr J, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med. 1999;131:363-375. 63. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998;280:1569- 75. 64. Ekor M. (2014). The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol. 4:177. 65. El-Kadiki A & Sutton AJ (2005) Role of multivitamins and mineral supplements in preventing infections in elderly people: systematic review and meta-analysis of ran- domised controlled trials. Br Med J 330, 871–873. 66. Ernst E. Funding research into complementary medicine: the situation in Britain. Complement Ther Med 1999; 7: 250–253. 67. Ernst E. Only 0.08% of funding for research in NHS goes to complementary medicine. Br Med J 1996; 313: 882. 68. Ernst, E. (2002). Toxic heavy metals and undeclared drugs in Asian herbal medicines. Trends Pharmacol. Sci. 23, 136–139. 69. European Commission (2002) Directive 2002/46/EC of the European Parliament and of the Council on 10 June 2002 on the approximation of the laws of the Member States relating to food supplements (accessed June 2010). 70. Everson, R. B., Wehr, C. M., Erexson, G. L. & MacGregor, J. T. (1988) Association of marginal folate depletion with increased human chromosomal damage in vivo: demon- stration by analysis of micronucleated erythrocytes. Journal of the National Cancer Institute, 80, 525–9. 71. Expert Group onVitamins and Minerals.Safe upper levels for vitamins and minerals, Food Standards Agency, London. 2003. Internet :http://www.food.gov.uk/multimedia/ pdfs/vitmin2003.pdf (accessed 10 May 2006). 72. Fairfield K.M., Fletcher H.R. Vitamins for Chronic Disease Prevention in Adults. Scientific Review. JAMA. 2002;287(23):3116-3126. doi:10.1001/jama.287.23.3116. 73. Farnsworth N. R., Fong H. H. S., Mahady G. B., WHO Monographs on Selected Medicinal Plants, vol. 1, World Health Organization, Geneva, Switzerland, 1999. 74. Fava M, Alpert J, Nierenberg AA, et al. A double-blind, randomized trial of St John’s wort, fluoxetine, and placebo in major depressive disorder. J Clin Psychopharm. 2005;25(5):441–447. 75. F-D-C Reports, Inc. 1997a. “The Tan Sheet: Dietary Supplement Sales up 16% to Approximately $10.3BIL.” Chevy Chase, MD: F-D-C Reports, Inc. 76. F-D-C Reports, Inc. 1997b. “The Tan Sheet: Nonprescription Pharmaceutical and Nutritionals.” Chevy Chase, MD: F-D-C Reports, Inc.